|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Stony Brook University |
|---|---|
| Information provided by: | Stony Brook University |
| ClinicalTrials.gov Identifier: | NCT00997659 |
Purpose
This research is to investigate the nutritional supplement chromium picolinate. A large number of people use chromium picolinate from health food stores to improve the function of the hormone insulin. The investigators are testing how effective this supplement is and are also monitoring its safety. In patients with diabetes, chromium has been shown to increase sensitivity to the hormone insulin. Since obesity can cause insensitivity or resistance to insulin, the investigators are studying obese individuals with documented insulin resistance. The investigators would like to know if chromium is also effective in treating the insulin resistance associated with obesity.
| Condition | Intervention |
|---|---|
|
Insulin Resistance Obesity |
Dietary Supplement: chromium picolinate |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Efficacy and Safety of Chromium as a Therapeutic Intervention for Insulin Resistance Associated With Obesity |
| Estimated Enrollment: | 40 |
| Study Start Date: | April 2007 |
| Estimated Study Completion Date: | May 2010 |
| Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| chromium picolinate: Experimental |
Dietary Supplement: chromium picolinate
1000 mg per day
|
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Dennis Mynarcik, PhD | (631) 444-3430 | dmynarcik@notes.cc.sunysb.edu |
| Contact: Teresa Hunt-Goncalves, NP | (631) 444-9362 |
| United States, New York | |
| Stony Brook University GCRC | Recruiting |
| Stony Brook, New York, United States, 11794 | |
| Contact: Dennis Mynarcik, PhD 631-444-3430 dmynarcik@notes.cc.sunysb.edu | |
| Contact: Teresa Hunt-Goncalves, NP (631) 444-9362 | |
| Principal Investigator: Dennis Mynarcik, PhD | |
More Information
| Responsible Party: | Stony Brook University ( Dennis Mynarcik, PhD ) |
| Study ID Numbers: | 2007-5689 |
| Study First Received: | October 16, 2009 |
| Last Updated: | October 16, 2009 |
| ClinicalTrials.gov Identifier: | NCT00997659 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
chromium picolinate insulin resistance obesity |
|
Obesity Metabolic Diseases Molecular Mechanisms of Pharmacological Action Chromium Growth Substances Physiological Effects of Drugs Picolinic acid Iron Chelating Agents Trace Elements Overweight Pharmacologic Actions |
Insulin Body Weight Hyperinsulinism Signs and Symptoms Hypoglycemic Agents Nutrition Disorders Overnutrition Chelating Agents Micronutrients Insulin Resistance Glucose Metabolism Disorders |